BOW050 (adalimumab biosimilar) - Epirus
Epirus: Q3 2015 Results (Epirus Biopharmaceuticals) - Nov 21, 2015 - Anticipated harmonized global filing for inflammatory diseases in 2018 
Anticipated regulatory • Biosimilar
http://ir.epirusbiopharma.com/releasedetail.cfm?ReleaseID=942787
 
Nov 21, 2015
 
.